Respiratory virus background immunity assessment
- Conditions
- Viral infection, respiratory tract infectionsInfections and Infestations
- Registration Number
- ISRCTN15445591
- Lead Sponsor
- Centre for Human Drug Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 3500
1. Aged 18-75 years and in good health; the upper age limit could be lowered for different executions of this protocol, but will never exceed 75 years
2. Good health, based upon the results of medical history
3. Subject has signed informed consent
1. Evidence of immunodeficiency in medical history
2. Prior use of immunosuppressive medication (systemic glucocorticoids 6 months prior to inclusion or any other systemic immunosuppressive medication at any time), immunoglobulins or systemic antiviral therapy)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method